PharmaShots | Incisive News in 3 Shots

Subscribe Now

KITE Study

Novartis Reports Results of Beovu (brolucizumab) in P-III KITE Study for Diabetic Macular Edema

Novartis Reports Results of Beovu (brolucizumab) in P-III KITE Study for Diabetic Macular Edema

September 14, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us